Immune checkpoint proteins, such as PD-1 and PD-L1, are frequently overexpressed in cancer cells and tumor-associated myeloid cells, leading to the suppression of immune surveillance by adaptive immune cells within the TME. The gene discussed is CD274; the disease is neoplasm.